76 related articles for article (PubMed ID: 30132107)
1. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
Kim H; Goo JM; Suh YJ; Park CM; Kim YT
Eur Radiol; 2019 Mar; 29(3):1586-1594. PubMed ID: 30132107
[TBL] [Abstract][Full Text] [Related]
2. Limited resection is comparable to lobectomy for tumor size ≤ 2 cm pulmonary invasive mucinous adenocarcinoma.
Lin W; Su H; Xie H; Xu L; Wang T; Wang L; Hu X; Zhao D; Zhu Y; Wang H; Jiang G; Xie D; Chen C;
World J Surg Oncol; 2024 Apr; 22(1):109. PubMed ID: 38664816
[TBL] [Abstract][Full Text] [Related]
3. Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.
Kameda K; Eguchi T; Lu S; Qu Y; Tan KS; Kadota K; Adusumilli PS; Travis WD
J Thorac Oncol; 2018 Dec; 13(12):1919-1929. PubMed ID: 30195703
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes.
Li W; Yang Y; Yang M; Song N; Wan Z; Lu Q; Shi J
Ann Surg Oncol; 2024 Jan; 31(1):167-177. PubMed ID: 37925652
[TBL] [Abstract][Full Text] [Related]
5. Prognostication of lung adenocarcinomas using CT-based deep learning of morphological and histopathological features: a retrospective dual-institutional study.
Lee T; Lee KH; Lee JH; Park S; Kim YT; Goo JM; Kim H
Eur Radiol; 2024 May; 34(5):3431-3443. PubMed ID: 37861801
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma.
Chen C; Chen ZJ; Li WJ; Deng T; Le HB; Zhang YK; Zhang BJ
J Int Med Res; 2024 Apr; 52(4):3000605241245016. PubMed ID: 38661098
[TBL] [Abstract][Full Text] [Related]
7. Controversies on lung cancers manifesting as part-solid nodules.
Yip R; Li K; Liu L; Xu D; Tam K; Yankelevitz DF; Taioli E; Becker B; Henschke CI
Eur Radiol; 2018 Feb; 28(2):747-759. PubMed ID: 28835992
[TBL] [Abstract][Full Text] [Related]
8. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
[TBL] [Abstract][Full Text] [Related]
9. CD44v6 downregulation as a prognostic factor for distant recurrence in resected stage I lung adenocarcinomas.
Yoshida C; Kadota K; Yamada K; Fujimoto S; Ibuki E; Ishikawa R; Haba R; Yajima T
Clin Exp Med; 2023 Dec; 23(8):5191-5200. PubMed ID: 37743425
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significances of cribriform pattern in lung adenocarcinoma.
Pyo JS; Lee BH; Min KW; Kim NY
Pathol Res Pract; 2024 Jan; 253():155035. PubMed ID: 38171080
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-Lymphocyte Ratio and Risk of Nodal Metastasis in Early-Stage Lung Adenocarcinoma: A Brief Report From a Multicentric Analysis.
Gallina FT; Chiappetta M; Tajè R; Forcella D; Sassorossi C; Congedo MT; Evangelista J; Sperduti I; Lococo F; Cappuzzo F; Melis E; Margaritora S; Facciolo F
Clin Lung Cancer; 2024 Jun; 25(4):e196-e200.e1. PubMed ID: 38627156
[No Abstract] [Full Text] [Related]
12. Development and Validation of a Pathology Image Analysis-based Predictive Model for Lung Adenocarcinoma Prognosis - A Multi-cohort Study.
Luo X; Yin S; Yang L; Fujimoto J; Yang Y; Moran C; Kalhor N; Weissferdt A; Xie Y; Gazdar A; Minna J; Wistuba II; Mao Y; Xiao G
Sci Rep; 2019 May; 9(1):6886. PubMed ID: 31053738
[TBL] [Abstract][Full Text] [Related]
13. No prognostic impact of staging bone scan in patients with stage IA non-small cell lung cancer.
Zheng X; Li C; Ai J; Dong G; Long M; Li M; Qiu S; Huang Y; Yang G; Zhang T; Li Z
Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38602614
[TBL] [Abstract][Full Text] [Related]
14. Chinese Herbal Prescription Fu-Zheng-Qu-Xie Prevents Recurrence and Metastasis of Postoperative Early-Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration.
Zhang S; Chen W; Wang Y; Wu J; Xu L; Yu Y; Tian J; Xu R; Fang Z; Jiang L; Luo Y; Li Y
Oxid Med Cell Longev; 2021; 2021():6673828. PubMed ID: 34055197
[TBL] [Abstract][Full Text] [Related]
15. Pathological T3 Non-Small Cell Lung Cancer with satellite nodules: Number or size, what does matter?
Bertoglio P; Gallina FT; Aprile V; Minervini F; Tajè R; La Porta M; Lenzini A; Ambrosi F; Kestenholz P; Lucchi M; Facciolo F; Solli P
Eur J Surg Oncol; 2024 May; 50(7):108400. PubMed ID: 38733923
[TBL] [Abstract][Full Text] [Related]
16. Comment on: Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
Yu T; Zhou X; Li M
Lung Cancer; 2024 Apr; 190():107534. PubMed ID: 38489996
[No Abstract] [Full Text] [Related]
17. Tumor spread through air space, the clinical implications for T factor and effects on the disease recurrence and prognosis.
Nakajima T; Morimoto J; Yoshino I
J Thorac Dis; 2018 Feb; 10(2):539-543. PubMed ID: 29607107
[No Abstract] [Full Text] [Related]
18. Validation of the Eighth Edition Clinical T Categorization System for Clinical Stage IA, Resected Lung Adenocarcinomas: Prognostic Implications of the Ground-Glass Opacity Component.
Kim H; Goo JM; Kim YT; Park CM
J Thorac Oncol; 2020 Apr; 15(4):580-588. PubMed ID: 31877384
[TBL] [Abstract][Full Text] [Related]
19. Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype.
Ye T; Deng L; Wang S; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Xie L; Gu W; Zhao Y; Fu F; Peng W; Chen H
J Thorac Oncol; 2019 Apr; 14(4):617-627. PubMed ID: 30659988
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated prognostic factors extractable from chest CT scans in patients with lung cancer.
Kim H; Park CM
Transl Lung Cancer Res; 2023 May; 12(5):1133-1139. PubMed ID: 37323175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
